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Abstract: Skeletal muscle is a regenerative tissue which can repair damaged myofibers through
the activation of tissue-resident muscle stem cells (MuSCs). Many muscle diseases with impaired
regeneration cause excessive adipose tissue accumulation in muscle, alter the myogenic fate of
MuSCs, and deregulate the cross-talk between MuSCs and fibro/adipogenic progenitors (FAPs),
a bi-potent cell population which supports myogenesis and controls intra-muscular fibrosis and
adipocyte formation. In order to better characterize the interaction between adipogenesis and
myogenesis, we studied muscle regeneration and MuSC function in whole body Pparg null mice
generated by epiblast-specific Cre/lox deletion (Pparg∆/∆). We demonstrate that deletion of PPARγ
completely abolishes ectopic muscle adipogenesis during regeneration and impairs MuSC expansion
and myogenesis after injury. Ex vivo assays revealed that perturbed myogenesis in Pparg∆/∆ mice
does not primarily result from intrinsic defects of MuSCs or from perturbed myogenic support from
FAPs. The immune transition from a pro- to anti-inflammatory MuSC niche during regeneration
is perturbed in Pparg∆/∆ mice and suggests that PPARγ signaling in macrophages can interact with
ectopic adipogenesis and influence muscle regeneration. Altogether, our study demonstrates that
a PPARγ-dependent adipogenic response regulates muscle fat infiltration during regeneration and
that PPARγ is required for MuSC function and efficient muscle repair.
Keywords: Skeletal muscle; regeneration; myogenesis; adipogenesis; muscle stem cells; satellite cells;
inflammation; PPARg
1. Introduction
Skeletal muscle is a highly plastic tissue, which can adapt to different metabolic or physical
challenges, such as physical activity, disuse, or injuries. When muscle fibers are damaged as
a consequence of intense exercise, trauma, surgery, or genetic diseases, complementary cellular
mechanisms allow skeletal muscle to regenerate and recover tissue architecture and functionality.
This regenerative capacity is primarily driven by muscle stem cells (MuSCs), also known as satellite
cells, which express the transcription factor paired box 7 (Pax7) [1,2]. As a consequence of injury,
MuSCs break quiescence and enter the cell cycle, undertake myogenic commitment after expansion,
and reconstitute the contractile architecture by forming fusing to damaged fibers or forming de novo
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myofibers [3,4]. Successful muscle regeneration is tightly dependent on a temporally controlled
inflammatory response. A first wave of pro-inflammatory macrophages clears cellular debris [5] and
promotes MuSC expansion while inhibiting their premature differentiation [6]. Pro-inflammatory
macrophages are then replaced by a second wave of anti-inflammatory and pro-regenerative
macrophages, which switches the muscle stem cell niche to a state permissive to fusion and
differentiation to allow regeneration to complete [5,6].
Infiltration of fat in skeletal muscle has been reported in various physiological and pathological
settings. In particular, intra-muscular adipose tissue (IMAT; [7,8]) accumulates during muscle diseases
with impaired regeneration such as sarcopenia, muscular dystrophies, and rotator cuff tears [9–13].
Genetic experiments in mice with depletion of Pax7+ MuSCs have demonstrated that MuSC failure
and impaired regeneration directly causes ectopic muscle adipogenesis and fibrosis [14,15], and other
studies have associated unsuccessful or delayed muscle regeneration with the development of muscle
ectopic fat and fibrosis [16–18]. Fibro/adipogenic progenitors (FAPs) are specific progenitor cells
residing in the stem cell niche that are distinct from MuSCs and can differentiate to adipocytes in vitro
and in vivo [3,19,20]. In response to injury, uncommitted FAPs activate and proliferate to support the
myogenic capacity of MuSCs [19–22]. The fate of FAPs is then precisely regulated during regeneration,
in particular through a cross-talk with immune cells where tumor necrosis factor α (TNFα) initially
promotes FAP amplification and survival during MuSC expansion, and transforming growth factor β1
(TGF-β1) subsequently induces FAP apoptosis in later phases of regeneration to limit uncontrolled
expansion of FAPs [23].
We and others have shown that various models of muscle injury induced by intra-muscular
injection of cardiotoxin (CTX) or glycerol lead to ectopic adipogenesis in muscle with accumulation of
fat containing cells between muscle fibers [24–27]. Under physiological conditions, this response
is transient and cleared during the terminal phases of regeneration. Given this observation,
we hypothesized that ectopic adipogenesis could be important for efficient regeneration and set-out to
test this possibility by interfering with adipogenesis through genetic modulation of the peroxisome
proliferator-activated receptor γ (PPARγ). PPARγ is a nuclear receptor activated by fatty acids and
eicosanoids and is the master regulator of the adipogenesis [28,29]. Pre-adipocytes cannot differentiate
in the absence of PPARγ, and PPARγ activation during adipocyte differentiation induces several
target genes required for cell cycle exit, adipogenic commitment, and triglyceride metabolism and
storage in lipid droplets [30–32]. During skeletal muscle regeneration, PPARγ is strongly upregulated
three days after injury [24], at the time where FAPs expand to support myogenesis. PPARγ is also
expressed in macrophages where it indirectly modulates MuSC function and regeneration via a GDF-3
mediated crosstalk in the muscle stem cell niche [33]. Total invalidation of PPARγ in mice is lethal,
and genetic studies in mice have largely focused on tissue-specific conditional knock-outs. Deletion
of PPARγ from adipose tissue caused lipodystrophy and confirmed the prominent role of PPARγ
in adipocyte differentiation and metabolism, while PPARγ deletion from skeletal muscle caused
insulin resistance [34,35]. PPARγ is also important in macrophages where it controls inflammation and
foam cell formation during atherosclerosis [36–38]. Recent work has demonstrated that the lethality of
PPARγ knock-out mice results from placental defects that can be overcome by using an epiblast-specific
Cre deleter which removes PPARγ in the entire embryo while maintaining its expression in the placenta
during pregnancy [39,40]. In the present study, we used this genetic model of whole-body PPARγ
deletion to study muscle regeneration. By analyzing histological and molecular readouts in vivo and
the cross-talk between FAPs and MuSCs in vitro, we demonstrate that the loss of PPARγ totally blunts
ectopic adipogenesis during muscle regeneration and alters MuSC function and regeneration.
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2. Results
2.1. PPARγ Deletion Completely Abolishes Ectopic Adipogenesis During Skeletal Muscle Regeneration
Several studies have reported an upregulation of PPARγ during skeletal muscle regeneration,
which precedes the infiltration of lipid-droplet positive cells [24,26]. One open question is whether the
induction of PPARγ is the causal mechanism leading to fat infiltration, and whether this infiltration is
triggered by the adipogenic differentiation of progenitors in mature adipocytes. In order to answer the
question, we used whole-body PPARγ null mice (Pparg∆/∆ mice) which were recently generated by
epiblast-specific Cre deletion which deletes PPARγ in the entire embryo but not in the placenta [40].
Using this strategy, Pparg∆/∆ mice are viable and totally lack mature adipocytes throughout the
body [40], but have a compensatory fat accumulation in non-adipose tissues leading to increased
body weight (Figure S1A). Muscle weight is also lower in Pparg∆/∆ mice than in control littermates
(Figure S1B), most likely because of impaired metabolic homeostasis and steatosis in these mice, as
these conditions have been shown to alter insulin and anabolic signaling in other settings [41,42].
Tibialis anterior muscle of Pparg∆/∆ mice and control littermates was injected intramuscularly with
glycerol to cause fatty muscle degeneration as previously reported [19,20,24,26] and intramuscular
fat infiltration was quantified by Oil Red O staining throughout the time course of regeneration (3,
7, and 14 days post-injury (dpi)). As expected, intramuscular fat infiltration peaked at 14 dpi in
control mice. In contrast, Pparg∆/∆ mice failed to induce ectopic adipogenesis as Pparg∆/∆ muscles were
completely devoid of any intra-muscular lipid accumulation (Figure 1A). The level of fat infiltration
in Pparg∆/∆ injured muscle was blunted by 98% (Figure 1B), and did not differ from non-injured
contralateral muscles used as control. Thus, muscle ectopic adipogenesis, which develops transiently
during regeneration, is due to bona fide adipocyte formation and fully relies on the presence of PPARγ.
To confirm the impaired adipogenic signature of Pparg∆/∆ mice, we freshly isolated FAPs by flow
cytometry and induced their differentiation into adipocytes ex vivo. As expected, approximately 45%
of control FAPs differentiated in adipocytes after induction. In contrast, ex vivo adipogenesis was
completely abolished in FAPs isolated from Pparg∆/∆ muscles (reported hereafter as Pparg∆/∆ FAPs)
(Figure 1C,D). The loss of adipogenic fate of Pparg∆/∆ FAPs did not primarily result from cell death
as a large number of undifferentiated KO FAPs remained in culture after differentiation (Figure 1E)
and Pparg∆/∆ FAPs could efficiently expand and proliferate ex vivo. Nevertheless, we detected
approximately 25% less Pparg∆/∆ than control FAPs after differentiation (Figure 1E), likely because
PPARγ is known to regulate pre-adipocyte clonal expansion, a process where adipogenic cells undergo
a final cell division to exit the cell cycle and trigger adipogenic commitment and differentiation [43].
Altogether, our results confirmed the role of PPARγ as a master regulator of adipogenesis, and extended
this observation to the context of intra-muscular adipogenesis. The complete absence of adipogenesis
and ectopic fat infiltration in Pparg∆/∆ muscle prompted us to use this model to investigate the influence
of ectopic adipogenesis on muscle stem cell function, myogenesis, and muscle regeneration.
Int. J. Mol. Sci. 2018, 19, 2044 4 of 17
Int. J. Mol. Sci. 2017, 18, x FOR PEER REVIEW  4 of 16 
 
 
Figure 1. Ectopic adipogenesis during muscle regeneration is abolished in PpargΔ/Δ mice. Tibialis 
anterior muscles from PpargΔ/Δ and control littermates mice were injured with 50% glycerol 
intramuscular injection and collected at 3, 7, and 14 days post injury (dpi), n ≥ 7 mice per group. (A) 
Representative image of tibialis anterior (TA) section of control (Ctl) and PpargΔ/Δ (KO) mice stained 
by Oil Red O at 14 dpi. Scale bars: 200 µm. (B) Quantification of the area covered by Oil Red O in 
uninjured muscle and at 3, 7, and 14 dpi in control and PpargΔ/Δ. (C–E) FAPs were isolated from control 
and PpargΔ/Δ muscle by flow cytometry and cultured in adipogenic conditions, with n ≥ 24 cell culture 
replicates pooled from at least three mice per genotype and replicated twice on different days. (C) 
Representative staining of lipid droplets by bodipy (green) and DNA (blue). Magnification: 20x 
objective. (D) Percentage of differentiated Bodipy-positive FAPs quantified by high content imaging. 
(E) Total number of FAPs quantified by high content imaging via the DAPI staining. *** p < 0.001 by 
one-way analysis of variance (ANOVA) followed by Bonferroni’s test (A) and by Mann–Whitney test 
(D,E). 
2.2. Loss of PPARγ Impairs Muscle Stem Cell Function and Cross-Talks with Myogenesis In Vivo 
To interrogate whether MuSC function and muscle repair are affected in PpargΔ/Δ mice, we first 
quantified the expression of Pax7 and MyoD, which are expressed by regenerating cells, during the 
time course of muscle repair. As expected, we observed a strong upregulation of Pax7 and MyoD at 
3 dpi, as a consequence of MuSC activation in response to injury (Figure 2A). Interestingly, the 
induction of Pax7 and MyoD was impaired in PpargΔ/Δ mice during the time course of regeneration. 
Similar analyses in contra-lateral (CL) muscles demonstrated that these myogenic markers were not 
deregulated in non-injured PpargΔ/Δ muscles, demonstrating that lack of PPARγ specifically impairs 
the myogenic activity of MuSCs after their activation in response to injury. In order to confirm the 
evidence obtained at a molecular level, we next analyzed the in vivo activity of MuSCs by 
immunofluorescence against Pax7. The total number of Pax7-positive MuSCs was lower in PpargΔ/Δ 
than control muscle after injury (Figure 2B,C), confirming that PpargΔ/Δ mice fail to efficiently amplify 
myogenic precursors during muscle regeneration. Altered amplification of PpargΔ/Δ MuSCs resulted 
from impaired proliferation of MuSCs as the number of Pax7+/Ki-67+ proliferating MuSCs was 
significantly reduced by approximately 45% in PpargΔ/Δ muscle (Figure 2B–D). 
Figure 1. Ectopic adipogenesis during muscle regeneration is abolished in Pparg∆/∆ mice. Tibialis anterior
muscles from Pparg∆/∆ and control littermates mice were injured with 50% glycerol intramuscular injection
and collected at 3, 7, and 14 days post injury (dpi), n≥ 7 mice per group. (A) Representative image of tibialis
anterior (TA) section of control (Ctl) and Pparg∆/∆ (KO) mice stained by Oil Red O at 14 dpi. Scale bars:
200 µm. (B) Quantification of the area covered by Oil Red O in uninjured muscle and at 3, 7, and 14 dpi in
control and Pparg∆/∆. (C–E) FAPs were isolated from control and Pparg∆/∆ muscle by flow cytometry and
cultured in adipogenic conditions, with n≥ 24 cell culture replicates pooled from at least three mice per
genotype and replicated twice on different days. (C) Representative staining of lipid droplets by bodipy
(green) and DNA (blue). Magnification: 20× objective. (D) Percentage of differentiated Bodipy-positive
FAPs quantified by high content imaging. (E) Total number of FAPs quantified by high content imaging via
the DAPI staining. *** p < 0.001 by one-way analysis of variance (ANOVA) followed by Bonferroni’s test
(A) and by Mann–Whitney test (D,E).
2.2. Loss of PPARγ Impairs Muscle Stem Cell Function and Cross-Talks with Myogenesis In Vivo
To interrogate whether MuSC function a d muscle repair re affected in Pparg∆/∆ mice, we first
quantified the expression of Pax7 and MyoD, which are expressed by regenerating cells, during
the time course of muscle repair. As expected, we observed a strong upregulation of Pax7 and
MyoD at 3 dpi, as a consequence of MuSC activation in response to injury (Figure 2A). Interestingly,
the induction of Pax7 and MyoD was impaired in Pparg∆/∆ mice during the time course of regeneration.
Similar analyses in contra-lateral (CL) muscles demonstrated that these myogenic markers were
not deregulated in non-injured Pparg∆/∆ muscles, demonstrating that lack of PPARγ specifically
impairs the myogenic activity of MuSCs after their activation in response to injury. In order to
confirm the evidence obtained at a molecular level, we next analyzed the in vivo activity of MuSCs by
immunofluorescence against Pax7. The total number of Pax7-positive MuSCs was lower in Pparg∆/∆
than control muscle after injury (Figure 2B,C), confirming that Pparg∆/∆ mice fail to efficiently amplify
myogenic precursors during muscle regeneration. Altered amplification of Pparg∆/∆ MuSCs resulted
from impaired proliferation of MuSCs as the number of Pax7+/Ki-67+ proliferating MuSCs was
significantly reduced by approximately 45% in Pparg∆/∆ muscle (Figure 2B–D).
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Figure 2. MuSC amplification and commitment are impaired in PpargΔ/Δ mice. Tibialis anterior (TA) 
muscles from PpargΔ/Δ and control littermates mice were injured with 50% glycerol intramuscular 
injection and collected at 3, 7, and 14 days post injury (dpi). (A) Pax7 and MoyD mRNA quantification 
by qPCR in injured (INJ) and non-injured contralateral (CL) muscles. Data are normalized to CL 
muscles of control mice per timepoint, n ≥ 7 mice per group. (B) Representative images of TA sections 
stained for Pax7, Ki-67, and DAPI at 7dpi. White arrows indicate Pax7+/Ki-67+ nuclei. Scale bar: 200µm. 
(C,D) In vivo quantification of total Pax7+ nuclei (C) and proliferating Pax7+/Ki-67+ nuclei (D) in 
injured muscles at 7dpi, with n = 4–5 mice per group. **** p < 0.0001, *** p = 0.001, ** p = 0.01, * p < 0.05 
by one-way ANOVA (A) or Mann–Whitney test (C,D). Unless otherwise indicated, statistical 
comparisons relate to the CL muscle of control mice. 
To investigate how the MuSC phenotype of PpargΔ/Δ mice influences myogenesis and muscle 
repair, we quantified the amount of regenerating fibers with centralized nuclei as well as well their 
cross-sectional area during the time course of muscle regeneration. Loss of PPARγ did not affect the 
size of the injured area as the percentage of fibers with centralized nuclei was equal in control and 
PpargΔ/Δ mice during the early steps of regeneration (Figure 3B). However, the muscle of PpargΔ/Δ mice 
failed to efficiently regenerate as they had more fibers with centralized nuclei at late stages of 
regeneration (Figure 3A,B), indicating that their recovery to fully matured fibers with peripherally 
located nuclei was delayed. At 7dpi when MuSCs start to fuse with damaged or newly formed fibers, 
fiber size distribution was significantly impaired in PpargΔ/Δ mice in a bimodal fashion (Figure 3C; 
gray arrows). The smallest fibers, which encompass the newly formed fibers through de novo MuSC 
fusion, were smaller in PpargΔ/Δ mice, indicating that the defective MuSC amplification in PpargΔ/Δ 
mice translates to perturbed myogenesis and altered MuSC fusion. The largest fibers, which likely 
correspond to the repair of pre-existing fibers that were only mildly damaged were larger in PpargΔ/Δ 
mice and this phenotype persisted at later time points of regeneration (Figure 3C), likely indicating 
that PPARγ can influence myofiber growth through additional mechanisms which are MuSC-
independent. Altogether, these results demonstrate that loss of PPARγ impairs MuSC expansion and 
myogenesis in vivo and cross-talks with muscle repair. 
Figure 2. MuSC amplification and commit ent are impaired in Pparg∆/∆ mice. Tibialis anterior (TA)
muscles from Pparg∆/∆ and control littermates mice were injured with 50% glycerol intramuscular
injection and collected at 3, 7, and 14 days post injury (dpi). (A) Pax7 and MoyD mRNA quantification
by qPCR in injured (INJ) and non-injured contralateral (CL) muscles. Data are normalized to CL
muscles of control mice per timepoint, n ≥ 7 mice per group. (B) Representative images of TA sections
stained for Pax7, Ki-67, and DAPI at 7dpi. White arrows indicate Pax7+/Ki-67+ nuclei. Scale bar:
200 µm. (C,D) In vivo quantification of total Pax7+ nuclei (C) and proliferating Pax7+/Ki-67+ nuclei
(D) in injured muscles at 7dpi, with n = 4–5 mice per group. **** p < 0.0001, *** p = 0.001, ** p = 0.01,
* p < 0.05 by one-way ANOVA (A) or Mann–Whitney test (C,D). Unless otherwise indicated, statistical
comparisons relate to the CL muscle of control mice.
To investigate how the MuSC phenotype of Pparg∆/∆ mice influences myogenesis and muscle repair,
we quantified the amount of regenerating fib rs with centralized nuclei as well as well their cross-sectional
area during the time course of muscle regeneration. Los of PPARγ did ot affect the size of the injured
area as the percentage of fibers with centralized nuclei was equal i control a d Pparg∆/∆ mice during he
early steps of regeneration (Figure 3B). Howev r, the muscle of Pparg∆/∆ mice fail d o fficiently regenerate
as they had more fib rs with c tralized nuclei at late stages of regeneratio (Figure 3A,B), indicating that
their cov ry o fully matured fibers with peripherally located nuclei was del yed. At 7dpi hen MuSCs
start t fuse with damaged or newly formed fibers, fiber size distribution was si nifica tly impaired in
Pparg∆/∆ mice in a b modal fashion (F gure 3C; gray arrows). The smallest fibers, which encompass the
newly formed fibers through de novo MuSC fusion, were smaller in Pparg∆/∆ mice, indicating that the
defective MuSC amplificat on in Pparg∆/∆ mice translates to perturb d myogenesis and altered MuSC
fusion. The l rgest fibers, which likely c rrespond to the repair of pre-existi g fib rs that were only mildly
damaged were larger in P rg∆/∆ mic and this phenotype persisted at later ti e points of regeneration
(Figure 3C), likely indicating that PPARγ c n influenc myofiber growth through additional mechanisms
which re MuSC-indepe dent. Altogether, these resul s demonstrate that loss of PPARγ impairs MuSC
expansion a myogenesis in vivo and cros -talks with muscle repair.
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Figure 3. Muscle regeneration is impaired in PpargΔ/Δ mice. (A) Representative images of PpargΔ/Δ and 
control muscle sections stained with Laminin and DAPI at 14dpi. Scale bar: 50 µm. (B) Quantification 
of the percentage of fibers possessing centralized nuclei at 7 and 14dpi, with n=7 mice per group. (C) 
Cumulative distribution of cross sectional area of regenerating fibers with centralized nuclei in 
regenerating muscles of PpargΔ/Δ and control littermates mice at 7dpi (left panel) and 14dpi (right 
panel). Gray arrows depict the bimodal differences of PpargΔ/Δ and control cross sectional area 
distributions. n = 7 mice per group. *** p = 0.001, ** p = 0.01, * p < 0.05 by Mann–Whitney test (B) or 
Kolmogorov–Smirnov test (C). 
2.3. PPARγ KO Does Not Directly Impair the Intrinsic Function of MuSC Function and the FAP/MuSC 
Cross-Talk Ex Vivo 
Since muscle regeneration is regulated by an integrated cooperation between many residing and 
recruited cell types in the MuSC niche, we asked whether the in vivo MuSC phenotype of PpargΔ/Δ 
mice is either due to a direct intrinsic role of PPARγ in MuSCs, or indirectly influenced by a PPARγ-
dependent paracrine signal from other cell types of the MuSC niche. As a first step, PPARγ expression 
in freshly isolated MuSCs and FAPs was compared to its expression in white adipose tissue (Figure 
4A). PPARγ expression was detected in MuSCs, but at lower levels than in FAPs and much lower 
than in adipose tissue (Figure 4A), thus making it unlikely that PPARγ could drive MuSC fate in a 
cell-autonomous fashion. This was confirmed by demonstrating that the lower activation and 
proliferation of MuSCs detected in vivo in PpargΔ/Δ mice was not reproduced in an ex vivo assay with 
Edu incorporation 1.5 and 3 days after MuSCs isolation from control and PpargΔ/Δ mice (Figure 4B,C). 
Surprisingly, the ex vivo activation during the first cellular division after exit of quiescence was even 
greater in PpargΔ/Δ cells than in control cells (Figure 4B). Given the low expression of PPARγ in MuSCs 
and the fact that the proliferation of PpargΔ/Δ MuSCs was normal and steady after 3 days of culture, 
higher ex vivo activation of PpargΔ/Δ MuSCs is likely caused by indirect mechanisms. This was further 
confirmed by assessing the terminal differentiation of PpargΔ/Δ MuSCs into myofibers after 6 days of 
ex vivo culture. Neither the number of differentiated myosin-heavy chain (MHC)-positive cells nor 
the fusion index of nuclei in multi-nucleated myofibers differed between PpargΔ/Δ and control MuSCs 
(Figure 4D). 
Fi re 3. uscle re e er ti is i ire i ar ∆/∆ ice. ( ) e rese t ti e i es f ar ∆/∆ an
co trol scle sectio s stai e it a i i a I at 14 i. Scale ar: 50 µ . (B) Quantification
of the percentage of fibers possessing centralized nuclei at 7 and 14dpi, with n=7 mice per group.
(C) Cumulative distribution of cross sectional area of regenerating fibers with centralized nuclei in
regenerating uscles of Pparg∆/∆ and control littermates mice at 7dpi (left panel) and 14dpi (right
panel). Gray arrows depict the bi odal differences of Pparg∆/∆ and control cross sectional area
distributions. n = 7 ice per group. *** p = 0.001, ** p = 0.01, * p < 0.05 by ann– hitney test (B) or
Kolmogorov–Smirnov test (C).
2.3. PP oes ot irectl I ir t I t i i i
Cross-Talk Ex Vivo
Since muscle regeneration is regulated by an integrated cooperation between many residing and
recruited cell types in the MuSC niche, we asked whether the in vivo MuSC phenotype of Pparg∆/∆ mice is
either due to a direct intrinsic role of PPARγ in MuSCs, or indirectly influenced by a PPARγ-dependent
paracrine signal from other cell types of the MuSC niche. As a first step, PPARγ expression in freshly
isolated MuSCs and FAPs was compared to its expression in white adipose tissue (Figure 4A). PPARγ
expression was detected in MuSCs, but at lower levels than in FAPs and much lower than in adipose tissue
(Figure 4A), thus making it unlikely that PPARγ could drive MuSC fate in a cell-autonomous fashion.
This was confirmed by demonstrating that the lower activation and proliferation of MuSCs detected in vivo
in Pparg∆/∆ mice was not reproduced in an ex vivo assay with Edu incorporation 1.5 and 3 days after
MuSCs isolation from control and Pparg∆/∆ mice (Figure 4B,C). Surprisingly, the ex vivo activation during
the first cellular division after exit of quiescence was even greater in Pparg∆/∆ cells than in control cells
(Figure 4B). Given the low expression of PPARγ in MuSCs and the fact that the proliferation of Pparg∆/∆
MuSCs was normal and steady after 3 days of culture, higher ex vivo activation of Pparg∆/∆ MuSCs is
likely caused by indirect mechanisms. This was further confirmed by assessing the terminal differentiation
of Pparg∆/∆ MuSCs into myofibers after 6 days of ex vivo culture. Neither the number of differentiated
myosin-heavy chain (MHC)-positive cells nor the fusion index of nuclei in multi-nucleated myofibers
differed between Pparg∆/∆ and control MuSCs (Figure 4D).
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Figure 4. PpargΔ/Δ MuSCs activate faster than control MuSCs ex vivo. (A) PPARγ mRNA quantified 
by qPCR in freshly isolated MuSCs, FAPs and mouse white adipose tissue (WAT). n = 4 mice (B,C) 
Relative number (top panel) and percentage of EdU+ (lower panel) MuSCs cultured for 36 h (B) or 72 
h (C) after FACS isolation. (D) Myogenic differentiation of PpargΔ/Δ and control MuSCs cultured for 
six days after FACS isolation. Relative quantification of the total number of nuclei having fused in 
MHC + myofibers is shown in the top panel, and fusion index (% nuclei in MHC + myofibers) is shown 
in the lower panel. (B,D) n ≥ 24 cell culture replicates pooled from at least three mice per genotype 
and replicated twice on different days. * p < 0.05; by Mann–Whitney test. 
We then tested whether PPARγ could indirectly regulate MuSC function by regulating the 
cellular cross-talk between MuSCs and other PPARγ-expressing accessory cells in the muscle stem 
cell niche. FAPs appeared as good candidates as they support MuSC activity as progenitors [19] and 
possess an adipogenic fate. We first evaluated how loss of PPARγ influences FAP expansion ex vivo 
using total cell counts and EdU incorporation to reveal activated and proliferating cells 2 and 6 days 
after isolation, respectively. After 2 days in culture, we did not detect any difference in the total FAP 
number, highlighting that both control and PpargΔ/Δ FAPs had similar adhesion and survival (Figure 
5A). Cell cycle entry assessed by Edu incorporation was faster in PpargΔ/Δ FAPs 2 days post-isolation 
(Figure 5A), but did not result in more FAPs or higher proliferation 6 days post-isolation (Figure 5B). 
Thus, while PPARγ is essential for FAP differentiation to adipocytes, it does not play an intrinsic role 
in the regulation of FAP expansion. We next interrogated the role of PPARγ in the cross talk between 
FAPs and MuSCs through direct ex vivo co-cultures. As expected, co-culture of MuSCs with control 
FAPs was beneficial for their myogenic differentiation in myosin-heavy chain positive myotubes 
(Figure 5C). However, PpargΔ/Δ FAPs also supported myogenic differentiation of MuSCs to a similar 
extent (Figure 5C). These results therefore revealed that in their undifferentiated precursor state, 
FAPs efficiently sustain the myogenic differentiation of MuSCs through PPARγ-independent 
mechanisms. 
i r 4. parg∆ ∆ t tifi
i fr s l i l ).
l ti l ercentage of EdU+ (lower panel) MuSCs cultured for 36 h (B) or
72 h (C) after FACS isolation. (D) Myogenic differen ation of Pparg∆/∆ and control MuSCs c ltured
for six days after FACS isolation. Relative quantification of the total number of l i i
fi rs is n i t e top anel, and fusion index (% nuclei in HC + fi ) i
i t e lo er panel. ( , ) ll lt li t l f t l t t i er ge t
re licate t ice on ifferent days. * p < . ; it t st.
e then tested whether PPARγ could indirectly regulate MuSC function by regulating the cellular
cross-talk between MuSCs and other PPARγ-expressing accessory cells in the muscle stem cell niche.
FAPs appeared as good candidates as they support MuSC activity as progenitors [19] and possess
an adipogenic fate. We first evaluated how loss of PPARγ influences FAP expansion ex vivo using
total cell counts and EdU incorporation to reveal activated and proliferating cells 2 and 6 days after
isolation, respectively. After 2 days in culture, we did not detect any difference in the total FAP number,
highlighting that both control and Pparg∆/∆ FAPs had similar adhesion and survival (Figure 5A).
Cell cycle entry assessed by Edu incorporation was faster in Pparg∆/∆ FAPs 2 days post-isolation
(Figure 5A), but did not result in more FAPs or higher proliferation 6 days post-isolation (Figure 5B).
Thus, while PPARγ is essential for FAP differentiation to adipocytes, it does not play an intrinsic role
in the regulation of FAP expansion. e next interrogated the role of PPARγ in the cross talk between
FAPs and uSCs through direct ex vivo co-cultures. As expected, co-culture of uSCs with control
FAPs was beneficial for their myogenic differentiation in myosin-heavy chain positive myotubes
(Figure 5C). However, Pparg∆/∆ FAPs also supported myogenic differentiation of MuSCs to a similar
extent (Figure 5C). These results therefore revealed that in their undifferentiated precursor state, FAPs
efficiently sustain the myogenic differentiation of MuSCs through PPARγ-independent mechanisms.
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2.4. Altered Infla atory Signatures i
ur results de onstrati that the intrinsic loss of PP in uSCs and F Ps does not directly
cause the uSC activation and regeneration defects of Pparg∆/∆ mice prompted us to evaluate for
a role of PPARγ in other cell types that remodel the stem cell niche during regeneration. In particular,
the fact t at s r l j ∆/∆ mice and only a fected upon uscle
re e i i ring the early steps of muscle repair sug ested a potential role of
PPARγ in a cell type r c uited to dam ged muscle after injury. We thus q antified the expr ssion level
of macrophage surface markers and chemokines in control a d Ppa g∆/∆ mice. General inflammatory
markers such as F4/80, CD11b, and CD11c were differentially regulated i injured muscles of Pparg∆/∆
vs control mice at various time points (Figure 6A), while the nduction of IL-1, TNF and IL-6 mRNA
in response to injury did n t change significan ly t 3dp between Pparg∆/∆ and control muscles
(Figure 6B). The analysis of anti-infl mmatory macrophage cell surface markers reve led a defect
in reg nerating muscl of Pparg∆/∆ mice, as deletion of PPARγ severely blunt d the induction of
the mann se r ceptor (MR) and the macrophage scavenger receptor (MRS1) at 3dpi (Figure 6C),
when the regen rating nich shifts to anti-inflammatory conditions to support myogenic co mitment.
Resolu ion of th IL-6 nflammatory cytokine production at 7dpi was als altere in Pparg∆/∆ (Figure 6B).
These observations highlight that PPARγ influences the temporal profiles of the inflammatory response
during muscle regeneration. Altogeth r, ou study demonst ates that whole body lo s of PPARγ
influences muscle regeneration by acting on MuSC function i directly thro gh various complementary
mechanis s in various cell types of the stem cell niche.
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3. Discus ion
Ectopic infiltration of adipocytes in skeletal muscle has been widely associated with altered muscle
function, mainly bec use adipose infiltration is observed in many muscle degenerative conditions
such as dy trop ie or rotator cuff tears [9–12]. In contrast, recent studies have s gg ted that muscle
adipogenesis may actually be a physiological process required for muscl plasticity, which ge s
deregulated and over-amplified during pathology. Firs , ectopic muscle ad pogenesis is detect d in
several models of efficient muscle regeneration [24–27], and this response is transi nt and cleared
during the terminal phases of muscle repair when myofibers return to homeostasis. In addition, the FAP
lineage can both support myoge esis and diffe entiate to intra-muscular adipocytes, with different
states of p rmissivity according to the patho-physiological status [19,20]. Finally, mus le adipogenesis
is blunted in response to unloading and lack of muscle co tr ction [25]. In the pre ent study, we have
demonstrated that the ectopic accu ulation of f t during muscle regeneration fully relies on the
adipogenic transcription factor PPARγ. Pparg∆/∆ mice are totally devoid of intra-muscular adipocytes
aft r muscle injury and Pparg∆/∆ FAPs completely lose the ability to differentiate to adipocytes. On top
of confi ming the dominant role of PPARγ on adipogenesis [40] in skeletal muscle, this r sult also
highligh s that muscle ectopic fat formation after injury is an active cellular process tightly regulated at
th molecular level, and not just the aspecific ac mu ation of cellular lipids from dam ged myofibers.
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Interestingly, our results consistently demonstrate that the absence of PPARγ and ectopic
adipocyte formation alter the activation and myogenic commitment of MuSCs in vivo. The induction
of Pax7 and MyoD as well as the proliferation of Pax7-positive MuSCs are impaired in the regenerating
muscle of Pparg∆/∆ mice. PPARβ/δ another member of the PPAR nuclear receptor family, has
previously been demonstrated to control MuSC function and muscle regeneration [44–46], most
likely through a direct effect on the myogenic lineage as Myf5-Cre conditional deletion of PPARγ is
sufficient to alter MuSCs and regeneration [44]. In contrast, the alterations of muscle regeneration
in Pparg∆/∆ mice in vivo did not result from cell autonomous defects linked to the absence of PPARγ
in MuSCs as PPARγ expression is low in MuSCs and the activation and proliferation of Pparg∆/∆
MuSCs was not impaired ex vivo. Thus, the perturbed regenerative response of Pparg∆/∆ mice support
the notion that a functional adipogenic response is required to efficiently sustain myogenesis during
physiological muscle healing. In particular, we can hypothesize that cellular and membrane lipids from
damaged myofibers are released in the muscle stem niche a few days after injury and need to be stored
intracellularly to avoid damage to regenerating fibers. Interestingly, the adipogenic lineage has also
been demonstrated to support self-renewal and regeneration in other organs. For example, adipocyte
precursors have been involved in skin epithelial stem cell activation in the hair follicle [47,48], and
the adipogenic lineage was shown to recruit fibroblasts during skin wound healing [49]. A cross-talk
between adipose-derived stem cells and chondrocytes has also recently been found in vitro, potentially
revealing similar cross-communications during cartilage repair [50].
Our study has analyzed muscle regeneration in a mouse model where PPARγ is deleted in
all cells and organs [39,40]. At the undifferentiated progenitor level, we demonstrated that control
and Pparg∆/∆ FAPs had a similar ability to support myogenesis. We also further showed that the
function of isolated Pparg∆/∆ MuSCs is not lower ex vivo. Surprisingly, Pparg∆/∆ MuSCs even activated
faster than control cells ex vivo, possibly because the lipodystrophy and metabolic phenotype of
Pparg∆/∆ mice alter MuSC quiescence in vivo and trigger earlier activation ex vivo. Given these
observations, it is therefore likely that impaired in vivo MuSC function in Pparg∆/∆ mice is indirect,
through a cross-talk with other cell types of the muscle stem cell niche or via systemic signals from
other tissues. Along this line, two mechanisms most likely cross-talk during regeneration. First,
the absence of adipogenic differentiation of Pparg∆/∆ FAPs can contribute to the in vivo phenotype by
controlling adipokine signals during adipogenic and myogenic differentiation. Second, the immune
signature is altered in the regenerating niche of Pparg∆/∆ mice, where anti-inflammatory macrophage
markers fail to get efficiently induced. Recent work has demonstrated that PPARγ in macrophages
regulates myogenesis and muscle repair via secreted paracrine signals [33]. Our results are consistent
with the indirect modulation of myogenesis via PPARγ in immune cells and fully supports the model
where macrophage PPARγ cross-talks with MuSCs through secreted cytokines. Interestingly, the fate
of FAPs is tightly controlled by inflammatory cytokines, which dynamically influence their expansion,
differentiation and apoptosis during the resolution of inflammation and the different phases of muscle
repair [23,51–53]. Thus, PPARγ most likely influences MuSCs and myogenesis indirectly via a complex
cross-talk between macrophages and FAPs.
Altogether, our work has demonstrated that PPARγ is required for ectopic adipocyte infiltration
during muscle regeneration and alters MuSC proliferation and myogenic commitment via indirect
cellular cross-talks in the stem cell niche. Genetic PPARγ invalidation in macrophages and bone
marrow transplant from PPARγ KO mice have already demonstrated that macrophages are required
for this cross-talk [33]. Further studies with cell-type specific invalidation of PPARγ, in particular
in FAPs, will be important to further refine the roles of the distinct cellular compartments of the
niche and the interactions between adipogenesis and myogenesis during muscle regeneration and
muscle diseases.
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4. Materials and Methods
4.1. Animals
Animals were housed under standard conditions and allowed to access to food and water ad
libitum. Since the whole-body Pparg null mice die during embryonic development as a result of
placental defects, we used mice obtained through an epiblast-specific Cre recombinase expression
(Sox2-Cretg/+:Pparg∆/em∆ mice, hereafter called Pparg∆/∆ mice) as it has been demonstrated that PPARγ
is necessary for placental function but not for embryo development [39]. The generation and breeding
of mice for these experiments was performed as previously described [40]. Briefly, Sox2-Cretg/+
male mice (Jackson Laboratory, Bar Harbor, ME, USA) were mated with female Pparg∆/+ mice [54]
to obtain male Sox2-Cretg/+:Pparg∆/+ mice that were next mated with Ppargfl/fl females to obtain
Sox2-Cretg/+:Pparg∆/em∆ mice (Pparg∆/∆) and Sox2-Cre+/+:Ppargfl/+ (control). All experimental animals
were breeding littermates of a mixed C57BL6/SV129 genetic background, and control animals were
PPARgfl/+ that do not express Sox2Cre. Only female mice were used in this study since adult male
Pparg∆/∆ mice present a higher mortality. For muscle regeneration experiments, 11–15 week old mice
were anaesthetized with 2% isoflurane and 50 uL of 50% v/v glycerol was injected into the tibialis
anterior (TA) muscle. Mice received buprenorphine (Temgesic) 0.1 mg/kd/day i.p. as analgesic during
the 48h following glycerol injection. Mice were sacrificed by CO2 inhalation followed by cervical
dislocation 3, 7, 14 days post-injury (dpi), and regenerating and contra-lateral TA muscles were cut
in half and snap-frozen in liquid nitrogen for molecular analyses or frozen in liquid nitrogen cooled
isopentane for histology. All in vivo experiments were performed following the regulations of the
Swiss Animal Experimentation Ordinance and approved by the ethical committee of the canton de
Vaud under license VD2818, 01 Mar 2014.
4.2. Muscle Progenitor Cell Isolation
For the isolation of muscle stem cells, uninjured hindlimb muscles representing various fiber
types (gastrocnemius/soleus/plantaris complex, tibialis anterior/EDL complex and quadriceps) were
collected and from Pparg∆/∆ mice and their control littermates and freshly digested with dispase II
(2.5 U/mL) (Roche, Basel, Switzerland), collagenase B (0.2%) (Roche), and MgCl2 (5 mM). Cells were
then incubated at 4 ◦C for 30 min with fluorescently-coupled antibodies against CD45 (Invitrogen,
Carlsbad, CA, USA) MCD4501 or MCD4528; dilution for both 1/25), CD31 (Invitrogen, RM5201 or
RM5228; dilution for both 1/25), CD11b (Invitrogen, RM2801 or RM2828; dilution for both 1/25), CD34
(BD Biosciences, 560230 or 560238; dilution for both 1/60), Ly-6A–Ly-6E (Sca1) (BD Biosciences,
Franklin Lakes, NJ, USA) 561021; dilution 1/150), α7-integrin (R&D, FAB3518N; dilution 1/30)
and CD140a (eBioscience, San Diego, CA, USA, 12-1401-81 or 17-1401-81; dilution for both 1/30).
Cell isolation was performed on a Beckman–Coulter Astrios Cell sorter; Beckman-Coulter, Brea,
CA, USA. MuSCs isolated by flow-cytometry were CD45−CD31−CD11b−Sca1−CD34+Integrinα7+;
fibro/adipogenic progenitors (FAPs) were CD45−CD31−CD11b−Sca1+CD34+PDGFRα+.
4.3. Cell Culture
MuSCs and FAPs were sorted in 96 well plates at a density of 600 cells per well. Freshly sorted cells
were grown in growth medium: 20 mM glucose DMEM, 20% heat-inactivated FBS, 10% inactivated
horse serum, 2.5 ng/mL bFGF (Invitrogen), 1% P/S + 1% L+-Glutamine, 1% Na-pyruvate (Invitrogen).
For MuSC activation 1µM EdU (5-Ethynyl-2′-deoxyuridine) was added to the growth medium after cell
sorting. Cells were then fixed 1.5 days after with 4% paraformaldehyde (PFA) for 15 min. For MuSC
proliferation, 1 µM EdU was added to the growth medium 3 days after cell sorting, for 2.5 h. Cells were
then fixed 15 min in 4% PFA. MuSC differentiation was induced after 4 days in culture by switching
to myogenic differentiation medium (20 mM glucose DMEM, 5% inactivated horse serum, 1% P/S).
Cells were cultured in these conditions for two days and then fixed in 4% PFA for 5 min. For FAP
activation 1 µM EdU was added to the growth medium after cell sorting. Cells were then fixed
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two days after with 4% PFA for 15 min. For FAP proliferation, 1 µM EdU was added six days after cell
sorting. Cells were then incubated for 6 h and fixed in 4% PFA for 15 min. For FAP differentiation, after
six days of culture in growth medium, the medium was replaced by adipogenic differentiation medium
for an additional seven days (20 mM glucose DMEM, 20% heat-inactivated FBS, 1% P/S, 0.25 µM
dexamethasone, 1 µg/mL insulin, 5 µM troglitazone, 0.5 mM isobutylmethylxanthine). For MuCS and
FAP co-cultures, we cultured PPARγ-KO MuSCs alone, or with WT or PPARγ-KO FAPs.
4.4. Immunocytochemistry for In Vitro Studies
EdU incorporation was revealed by the Click-iT assay (Molecular Probes, Eugene, OR, USA) according
to manufacturer’s instructions. After fixation, cells were permeabilized during 20 min in PBTX 0.5%, stained
with the Click-iT reaction mix, and counterstained with DAPI. For myosin heavy vhain (MHC) staining,
after fixation, cells were permeabilized using EtOH/MetOH (v/v) for 5 min, incubated for 1 h with the
primary antibody anti-MHC 1/200 (Millipore clone A4.1025) in PBS, 1% Horse Serum at room temperature,
and incubated during 30 min with the secondary antibody Alexa488 anti-mouse IgG diluted at 1/1000
(Life Tech (Carlsbad, CA, USA) A-10680) and Hoeschst33342 in PBS, 1% horse serum at room temperature.
Fusion index was determined as the percentage of nuclei located within MHC positive fibers. Image
acquisition was performed using the ImageXpress (Molecular Devices, San Jose, CA, USA) platform.
Quantifications were done using the MetaXpress software (Molecular Devices).
4.5. Immunohistochemistry for In Vivo Studies
TA muscles were frozen in isopentane and cooled with liquid nitrogen. Sections of 10 µm were
obtained after sectioning on a cryostat. For Pax7-Ki67 staining, sections were allowed to dry for 10 min
and then fixed 10 min in 4% PFA. Tissue sections were permeabilized by applying cold methanol (−20 ◦C)
for 6 min. For the antigen revealing, slides were immersed in a glass container filled with hot acid citric
(0.01 M), and then in boiling water bath for 5 min, repeated twice. Slides were then blocked 3 h in blocking
solution (IgG-free Bovine Serum Albumin (BSA) 4% (Jackson #001-000-162), followed by 30 min incubation
with Goat-anti-mouse FAB (Jackson #115-007-003) diluted 1/50 in PBS. Rabbit anti-Ki67 polyclonal (Abcam,
Cambridge, United Kingdom, #ab15580) was used (1/200) and chicken anti-laminin (Life-Span Bioscience,
Seattle, WA, USA, #LS-C96142) antibodies were incubated 3 h in blocking solution in1/200 and 1/300
dilution, respectively. Mouse anti-Pax7 (DSHB, purified) IgG1 (2.5 µg/mL) was then incubated overnight
at 4 ◦C. Secondary antibodies (Alexa488-Goat anti-rabbit (1/1000) and Alexa647-Goat anti-chicken (1/1000)
were incubated for 1 h in blocking solution. Pax7 signal was further amplified using a goat-anti mouse
IgM1-biotin (Jackson), followed by a streptavidin (1/2000) treatment, together with Hoechst.
For Oil-Red-O staining slides were air-dried and then incubated in 50% ethanol during 30 min,
followed by 15 min incubation in 2.5 g/L oil-red-O solution in 70% ethanol and 1 min washes in 50%
ethanol and water. Finally, slides were counterstained with Mayer’s hematoxylin. Stained tissues were
imaged using an Olympus VS120 virtual microscopy slide scanning system and analyzed using the
VS-ASW FL software measurement tools. The Pax7-Ki67 double positive nuclei (DAPI positive) were
counted by randomly selecting four or more areas within the injured region. Fiber size and Oil-Red-O
area analyses were performed on an automatized software developed in house.
For BODIPY staining, BODIPY 493/503 (4,4-difluro-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene,
Thermo Fisher Scientific, Waltham, MA, USA) was used according to manufacturer’s instructions.
Images were acquired with a Leica microscope (DMI4000B Leica widefield inverted microscope; Leica,
Wetzlar, Germany), at 20×magnification.
4.6. Quantitative PCR
RNA was extracted from sorted cells or muscles and white adipose tissue using RNeasy Micro Kit
(Qiagen, Hilden, Germany) or miRNeasy Mini Kit (Qiagen), respectively. According to the manufacturer’s
instruction, cells were stored in RTL buffer and frozen after the FACS sorting. RNA samples were processed
by reverse transcription (high capacity cDNA reverse transcription kits, Invitrogen) using random primers
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(High Capacity cDNA Reverse Transcription Kit, Applied Biosystems, Foster City, CA, USA. All of the
quantitative PCRs were performed using the SybR Green I master kit (Roche) on a LightCycler 480.
For sorted cells and adipose tissue, reference gene HPRT was selected. PPARγ primers were designed on
the gene region deleted in the KO mice:
Forward: AAGAGCTGACCCAATGGTTG, reverse: GCATCCTTCACAAGCATGAA. For muscles,
three reference genes (ATP5b, EIF2a, and PSMB4) were selected from previous micro-array data on the
base of their stability through the different time points of regeneration.













ITGAM (CD11b) forward: GCCTGTGAAGTACGCCATCT
ITGAM (CD11b) reverse: GCCCAGGTTGTTGAACTGGT;
ITGAX (CD11c) forward: ACACTGAGTGATGCCACTGT
ITGAX (CD11c) reverse: TTCGGAGGTCACCTAGTTGGG;
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4.7. Statistical Analysis
In vitro experiments were performed in at least three independent replicates from different mice,
using several cell culture replicates from the same isolation. All of the data are expressed as mean value
+ the standard error of the mean (s.e.m.). For statistical analysis, GraphPad Prism (GraphPad Software
Inc., La Jolla, CA, USA) was used. Statistical significance of two-group comparisons was assessed
by a non-parametric Mann–Whitney test which does not assume normal distribution, using variance
correction when required. For comparison of more than two groups, one-way ANOVA followed by
Bonferroni multiple-comparison test was used.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/19/7/
2044/s1.
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